PharmiWeb.com - Global Pharma News & Resources
06-Jun-2023

Rare Disease Genetic Testing Market Growing to Exhibit a Striking Growth with CAGR of 12.26% by 2029, Size, Share, Trends, Competitive Scenario and Industry Growth Analysis

An international  Rare Disease Genetic Testing Market   research report provides information about all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands while giving a synopsis of market definition, classifications, and market trends. The report defines CAGR value fluctuations during the forecast period of 2022-2029 for the market. By knowing the marketing strategies of rivals, businesses can decide upon innovative ideas and striking sales targets. The data mentioned in the persuasive Rare Disease Genetic Testing Market document also makes customers or other market participants attentive about the problems they may face while operating in this market over a longer period of time.

The market study carried out in the finest Rare Disease Genetic Testing Market report analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis. Moreover, analysis and estimation of important industry trends, market size, and market share are also covered in this market report. Rare Disease Genetic Testing Market research report forecasts the size of the market with respect to the information on main retailer revenues, development of the Healthcare industry by upstream and downstream, industry progress, key companies, along with market segments and application.

Data Bridge Market Research analyses that the rare disease genetic testing market which was USD 785.8 million in 2021, is expected to reach USD 1982.04 million by 2029, at a CAGR of 12.26% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-rare-disease-genetic-testing-market

Genetic testing is a diagnostic tool that not only aids in the identification of specific disease manifestations but also in determining the underlying causes of genetic disorders. Genetic testing has a variety of advantages such as confirming a diagnosis, determining the cause of unexplained symptoms, and identifying treatment options, including clinical trials. Genetic testing refers to a wide range of applications, ranging from family history collection and evaluation to whole genome screening. Each test has its own set of advantages and disadvantages based on the technology used and the indication for the test. A rare disease refers to a condition, disorder or disease that affects a small percentage of the population at any given time. For instance, in the European Union, it affects fewer than 1 in 2,000 individuals, in the United States, a rare disease is defined as a disease that affects less than 200,000 individuals.

Some of the major players operating in the rare disease genetic testing market are:

  • Quest Diagnostics Incorporated (U.S.)
  • Centogene N.V. (Germany)
  • Strand Life Sciences (Bengaluru)
  • Ambry Genetics (U.S.)
  • PerkinElmer, Inc. (U.S.)
  • Macrogen, Inc. (South Korea)
  • Baylor Genetics (U.S.)
  • HNL Lab Medicine (U.S.)
  • Preventiongenetics (U.S.)
  • 3billion, Inc. (South Korea)
  • Arup Laboratories (U.S.)
  • HNL Lab Medicine (U.S.)
  •  Preventiongenetics (U.S.)
  • Invitae Corporation (U.S.)
  •  Eurofins Scientific (Luxembourg)
  •  Strand Life Sciences (India)
  •  Realm IDX, Inc. (China)
  •  Myriad Genetics, Inc. (U.S.)
  •  Laboratory Corporation of America Holdings (U.S.)
  •  Opko Health, Inc. (U.S.)

Recent developments

  • In December 2020, Cell ID Pte. Ltd., a Singapore-based company that manufactures genetic testing products, will launch the Quiz PCR Biochip, a portable genetic test for COVID-19. This is a portable palm-sized moveable genetic test kit that uses an app to determine whether or not a person has COVID-19. This device also included a QR code for tracking purposes. The device employs pooled screening technology. This is easily portable and can conduct tests at any time
  • In January 2022, Exact Sciences, a US-based manufacturer of genetic testing tools and a molecular diagnostics company acquired Prevention Genetics for $190 million. Exact Sciences hopes to increase hereditary cancer testing for more patients as a result of this acquisition

Visit full Study Report @ https://www.databridgemarketresearch.com/reports/global-rare-disease-genetic-testing-market

Global Rare Disease Genetic Testing Market Scope

The rare disease genetic testing market is segmented on the basis of disease type, technology, speciality, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Type

  • Neurological Disorders
  • Immunological Disorders
  • Hematology Diseases
  • Endocrine
  • Metabolism Diseases
  • Cancer
  • Musculoskeletal Disorders
  • Cardiovascular Disorders (CVDs)
  • Dermatology Disease
  • Others

Technology

  • Next-Generation Sequencing (NGS)
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

Specialty

  • Molecular Genetic Tests
  • Chromosomal Genetic Tests
  • Biochemical Genetic Tests

End Use

  • Research Laboratories
  • CROs
  • Diagnostic Centers
  • Hospitals
  • Clinics

Let’s discuss the specifics of the report, including what you will receive and how it can benefit you:

  • It is crucial to identify audiences before beginning a campaign. In addition to this vital to know which countries to penetrate, we can provide you information.
  • It allows you to determine where to focus your efforts and which regions competition are located. You will be looking at the global market scenario, along with the GDP Growth of Rare Disease Genetic Testing Market  that particular region. In this way, an accurate assessment of the global market is made possible.
  • To stay competitive, every organization must stay one step ahead. By working with us, you will get a better understanding of your competitors.
  • You will also be presented with several competitive profiles, along with their updated financials, latest R&D developments, and projected growth for the next few years. We will also be informing you about recent developments to keep you up-to-date and allow you to take appropriate action.
  • Besides analyzing the segments and growth rates, we will also help you find out the key players in this industry and identify what previous developments have taken place. To help you focus on the right segments, we will provide a 360-degree snapshot of this market.

Complete Report Details with Facts and Figures along respective Images and Graphs (TOC) https://www.databridgemarketresearch.com/toc/?dbmr=global-rare-disease-genetic-testing-market

 Browse More Reports

Global Hemodialysis Services Market Analysis, Demand, Growth, Technology Trends, Key Findings and Forecast

https://www.databridgemarketresearch.com/reports/global-hemodialysis-services-market

Global Large-Joint Reconstructive Implants Market Analysis, Size, Share, Growth, Trends and Forecast Opportunities

https://www.databridgemarketresearch.com/reports/global-large-joint-reconstructive-implants-market

Global Apheresis Market Trends, Growth, Analysis, Opportunities and Overview

https://www.databridgemarketresearch.com/reports/global-apheresis-market

Global Diabetes Monitors Market| Analysis by Industry Trends, Size, Share, Company Overview, Growth, Development and Forecast

https://www.databridgemarketresearch.com/reports/global-diabetes-monitors-market

Global Automated Suturing Devices Market| Outlook, Growth by Top Companies, Regions, Types, Applications, Drivers, Trends & Forecast

https://www.databridgemarketresearch.com/reports/global-automated-suturing-devices-market

Global Smart Medical Devices Market- Trends, Market Share, Industry Size, Growth, Opportunities and Forecast

https://www.databridgemarketresearch.com/reports/global-smart-medical-devices-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com

Editor Details

  • Company:
    • The Wire Times
Last Updated: 06-Jun-2023